Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Chewy (CHWY)

Chewy Adds Dr. Nat Goldhaber to Board as Independent Class I Director

Neutral Impact 2 of 5 leadership Written later

Chewy expanded its board from thirteen to fourteen directors on April 24, 2025, and appointed Dr. Nat Goldhaber to fill the new seat as a Class I director with a term ending at the 2026 annual meeting. The board determined he is independent under SEC and NYSE rules, and he will receive the company's standard non-employee director pay. The change adds one board member and does not involve a change in executive leadership.

Key points

  • Board size increased from thirteen to fourteen directors on April 24, 2025
  • Dr. Nat Goldhaber appointed as a Class I director, term expiring at the 2026 annual meeting
  • Board determined Dr. Goldhaber is independent under SEC and NYSE rules
  • He receives standard non-affiliated director compensation and an indemnification agreement

The filing

CompanyChewy (CHWY)
Form8-K, current report
Filed with the SECApr 25, 2025, 4:10 PM ET
Accession number0001193125-25-096774

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:17 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 25, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.